XML 26 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Impairment, Restructuring and Other Charges
9 Months Ended
Mar. 31, 2021
Impairment, Restructuring and Other Charges  
Impairment, Restructuring and Other Charges

7. Impairment, Restructuring and Other Charges

We endeavor to align our global capacity and infrastructure with demand by our customers as well as fully integrate acquisitions and thereby improve operational efficiency.

During the three months ended March 31, 2021, we recognized a total net benefit of ($0.3) million which included a net benefit of ($0.7) million for reimbursements from our insurance carriers for covered legal charges. We also incurred charges of $0.2 million for employee terminations and $0.2 million for facility closure and operational efficiency activities.

During the nine months ended March 31, 2021, we incurred a total net expense of $7.9 million which included $7.2 million for exit activities associated with an expired turnkey contract in Mexico. Such exit costs include $2.8 million for employee terminations, $1.1 million for facility closure and other exit costs, direct transaction costs of $2.7 million, and $0.6 million for right-of-use asset impairment for a leased facility. We also incurred costs of $1.6 million for other employee terminations and facility closure costs for operational efficiency activities and $0.3 million for acquisition-related activities.  We also recognized a net benefit of ($1.2) million for reimbursements from our insurance carriers for covered legal charges.

During the three and nine  months ended March 31, 2020, we abandoned a non-core product line in our Healthcare division which resulted in the write-off of assets, including intangible and fixed assets, totaling $3.3 million as we determined that these assets had no value and were permanently impaired. In addition, we continued to recover certain legal costs related to class action litigation and government investigations through insurance reimbursement. We also incurred additional legal fees related to these matters as well as restructuring charges by the divisions as noted in the tables below. This resulted in a net expense of $4.5 million and $1.5 million during the three and nine months ended March 31, 2020, respectively.

The following tables summarize impairment, restructuring and other charges (benefit), net for the periods set forth below (in thousands):

Three Months Ended March 31, 2020

Optoelectronics and

Healthcare

Manufacturing

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Impairment charges

$

$

3,258

$

$

$

3,258

Acquisition-related costs

107

    

41

155

303

Employee termination costs

328

466

259

50

1,103

Facility closures/consolidation

 

30

 

 

 

 

30

Legal costs (recoveries), net

 

 

 

 

(146)

 

(146)

Total expensed

$

465

$

3,724

$

300

$

59

$

4,548

Three Months Ended March 31, 2021

Optoelectronics and

Healthcare

Manufacturing

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

22

$

$

$

$

22

Employee termination costs

213

213

Facility closures/consolidation costs (benefit)

166

166

Legal costs (recoveries), net

 

 

 

 

(686)

 

(686)

Total expensed (benefit), net

$

401

$

$

$

(686)

$

(285)

Nine Months Ended March 31, 2020

    

    

    

Optoelectronics and

    

    

Healthcare

Manufacturing

Security Division

Division

Division

Corporate

Total

Impairment charges

$

$

3,258

$

$

$

3,258

Acquisition-related costs

 

107

 

 

41

 

155

303

Employee termination costs

734

466

277

119

1,596

Facility closures/consolidation

 

30

 

 

 

 

30

Legal costs (recoveries), net

 

 

 

 

(3,667)

 

(3,667)

Total expensed

$

871

$

3,724

$

318

$

(3,393)

$

1,520

Nine Months Ended March 31, 2021

    

    

    

Optoelectronics and

    

    

Healthcare

Manufacturing

Security Division

Division

Division

Corporate

Total

Impairment charges

$

552

$

$

$

$

552

Acquisition-related costs

250

27

277

Employee termination costs

 

4,010

 

 

146

 

 

4,156

Mexico transaction costs

2,691

2,691

Facility closures/consolidation costs

 

1,420

 

 

 

 

1,420

Legal costs (recoveries), net

 

 

 

 

(1,184)

 

(1,184)

Total expensed (benefit), net

$

8,923

$

27

$

146

$

(1,184)

$

7,912

The accrued liability for restructuring and other charges is included in other accrued expenses and current liabilities in the condensed consolidated balance sheet. The changes in the accrued liability for restructuring and other charges for the nine-month period ended March 31, 2021 were as follows (in thousands):

Facility

Employee

Closure/

Termination

Consolidation

Acquisition-

Legal Costs and

    

Costs

    

Cost

    

Related Costs

    

Settlements

    

Total

Balance as of June 30, 2020

$

545

$

201

$

$

1,882

$

2,628

Restructuring and other charges (benefit), net

 

4,156

 

1,420

 

277

 

(1,184)

 

4,669

Payments, adjustments and reimbursements, net

 

(4,570)

 

(1,501)

 

(277)

 

748

 

(5,600)

Balance as of March 31, 2021

$

131

$

120

$

$

1,446

$

1,697